Avacincaptad pegol

Therapeutic indications

Avacincaptad pegol is indicated for:

Geographic atrophy secondary to age-related macular degeneration

Population group: only elderly (65 years old or older)

Nonexudative age-related macular degeneration

For this indication, competent medicine agencies globally authorize below treatments (click for details):


Avacincaptad pegol is contraindicated in the following cases:

Ocular or periocular infections

at least one of
Eye infection
Infection of skin of eyelid and periocular region

Active intraocular inflammation


Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.